Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

近期由高福院士领衔的研究团队对牛传播H5N1 禽流感病毒血凝素（HA）蛋白的受体结合特性、组织嗜性及其结构变化开展了深入研究，研究结果阐明了HA蛋白受体偏好性的分子基础，并提示了病毒的潜在流行风险和对这一新发病原体持续监测的迫切需求。研究成果以题为“Receptor Binding, Structure, and Tissue Tropism of Cattle-Infecting H5N1 ...

近期，高福院士研究团队对牛传播H5N1禽流感病毒血凝素（HA）蛋白的受体结合特性、组织嗜性及其结构变化开展了深入研究，研究结果阐明了HA蛋白受体偏好性的分子基础，并提示了病毒的潜在流行风险和对这一新发病原体持续监测的迫切需求。相关研究成果以“Receptor Binding, Structure, and Tissue Tropism of Cattle-Infecting H5N1 Avian ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), a biopharmaceutical company with a market capitalization of $2.68 billion ...